Fabio Pace

Identifying the next targets in IBD: pathobionts and their clinical impact

Recent studies have identified various bacterial and fungal pathobionts in patients with CD and UC.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top